NLV Partners is a venture capital firm that specializes in investing in early-stage technology startups. The company provides funding, mentorship, and strategic support to entrepreneurs with innovative solutions in various sectors. NLV Partners is known for its hands-on approach and extensive network within the tech industry, helping startups to scale and succeed in competitive markets.

Vijay Lathi

James Niedel

Philippe Chambon

Jeani Delagardelle

NLV Partners

Alliance Consumer Growth is a private equity firm that invests in and partners with consumer and retail brands across various sectors including food & beverage, personal care, beauty, pet products, restaurants, and apparel.

Alliance Consumer Growth

Newgen Capital is an investment brand that focuses on early-stage venture capital funds, actively participating as a limited partner in various funds, according to self-described characteristics.

Newgen Capital

NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in venture capital funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.

CRISPR Therapeutics

Deciphera Pharmaceuticals

Bellus Health

CareDx

Karyopharm Therapeutics

TigerConnect

Cogent Biosciences

ObsEva

Alector

Aptinyx

Chimerix

Dice Therapeutics

Passage Bio

Arvinas

MEI Pharma

Neuronetics

Harpoon Therapeutics

iRhythm Technologies

Iterum Therapeutics

New Leaf Venture Partners

Congratulations to New Leaf portfolio company BrightInsight for making the 2023 Deloitte Technology Fast 500! 

Congratulations to NLV portfolio company Crinetics Pharmaceuticals on an upsized financing raising $350 million!


Congratulations to NLV portfolio company Rocket Pharmaceuticals on raising $175 million! 


Congratulations to New Leaf portfolio company Bluesight (formerly Kitcheck). Bluesight received a strategic investment by Thoma Bravo. This will support Bluesight's acquisition in Medacist. We are excited to be a major stakeholder in Bluesight's next phase of growth.

https://lnkd.in/e_gMDzTx 

Congratulations to New Leaf portfolio company DICE Therapeutics on the announcement that it is being acquired by Eli Lilly and Company!

Read all about it here:
https://lnkd.in/eFqTtVuJ


Metric
Company Name	NLV Partners	Alliance Consumer Growth	Newgen Capital
Symbol
MSH ID	COM:NLVPARTNERS	COM:ACGPARTNERS	COM:NEWGENVC
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance
Industry	Venture Capital	Private Equity	Venture Capital
Country	US	US	CN
Stage
Employee Count	16	13
Website	nlvpartners.com	acgpartners.com	newgenvc.com
LinkedIn	new-leaf-venture-partners	alliance-consumer-growth-llc	newgen-vc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.71K	205
Web Traffic Growth	-0.18	0.72
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NLVPARTNERS

NLV Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue